Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- ADELSTEIN S. J., COOMBS T. L., VALLEE B. L. Metalloenzymes and myocardial infarction. I. The relation between serum copper and ceruloplasmin and its catalytic activity. N Engl J Med. 1956 Jul 19;255(3):105–109. doi: 10.1056/NEJM195607192550301. [DOI] [PubMed] [Google Scholar]
- BARON D. N., ALEXANDER C. P., BELL J. L., OAKLEY C. M. Serum transaminase estimation in the investigation of myocardial infarction. Q J Med. 1958 Oct;27(108):533–541. [PubMed] [Google Scholar]
- BING R. J., CASTELLANOS A., GRADEL E., LUPTON C., SIEGEL A. Experimental myocardial infarction: circulatory, biochemical and pathologic changes. Am J Med Sci. 1956 Nov;232(5):533–554. [PubMed] [Google Scholar]
- BRUNS F. Bestimmung und Eigenschaften der Serumaldolase. Biochem Z. 1954;325(2):156–162. [PubMed] [Google Scholar]
- CH'EN P. E. Abnormalities of copper metabolism in Wilson's disease; a preliminary report. Chin Med J. 1957 Nov;75(11):917–924. [PubMed] [Google Scholar]
- CHINSKY M., WOLFF R. J., SHERRY S. Serum transaminase activity; a comparison of the pyruvic and oxalacetic transaminases. Am J Med Sci. 1957 Apr;233(4):400–408. doi: 10.1097/00000441-195704000-00006. [DOI] [PubMed] [Google Scholar]
- DEWAR H. A., ROWELL N. R., SMITH A. J. Serum glutamic oxalacetic transaminase in acute myocardial infarction. Br Med J. 1958 Nov 8;2(5105):1121–1125. doi: 10.1136/bmj.2.5105.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GOBLE A. J., O'BRIEN E. N. Acute myocardial ischaemia: significance of plasma-transaminase activity. Lancet. 1958 Oct 25;2(7052):873–877. doi: 10.1016/s0140-6736(58)92305-5. [DOI] [PubMed] [Google Scholar]
- LOSNER S., VOLK B. W., ARONSON S. M. Diagnostic aids in acute myocardial infarction: clinical and experimental. Am Heart J. 1957 Aug;54(2):225–234. doi: 10.1016/0002-8703(57)90150-3. [DOI] [PubMed] [Google Scholar]
- MARKOWITZ H., GUBLER C. J., MAHONEY J. P., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome. J Clin Invest. 1955 Oct;34(10):1498–1508. doi: 10.1172/JCI103201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- RAVIN H. A. Rapid test for hepatolenticular degeneration. Lancet. 1956 May 19;270(6925):726–727. doi: 10.1016/s0140-6736(56)90751-6. [DOI] [PubMed] [Google Scholar]
- REITMAN S., FRANKEL S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957 Jul;28(1):56–63. doi: 10.1093/ajcp/28.1.56. [DOI] [PubMed] [Google Scholar]
- SIEGEL A., BING R. J. Plasma enzyme activity in myocardial infarction in dog and man. Proc Soc Exp Biol Med. 1956 Apr;91(4):604–607. doi: 10.3181/00379727-91-22344. [DOI] [PubMed] [Google Scholar]
- VALLEE B. L. The time course of serum copper concentrations of patients with myocardial infarctions. I. Metabolism. 1952 Sep;1(5):420–434. [PubMed] [Google Scholar]
- VOLK B. W., LOSNER S., ARONSON S. M., LEW H. The serum aldolase level in acute myocardial infarction. Am J Med Sci. 1956 Jul;232(1):38–passim. doi: 10.1097/00000441-195607000-00007. [DOI] [PubMed] [Google Scholar]
- WHITE L. P. Serum enzymes. I. Serum lactic dehydrogenase in myocardial infarction. N Engl J Med. 1956 Nov 22;255(21):984–988. doi: 10.1056/NEJM195611222552103. [DOI] [PubMed] [Google Scholar]